Trials / Sponsors / Nkarta, Inc.
Nkarta, Inc.
Industry · 4 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2) Systemic Sclerosis, Idiopathic Inflammatory Myopathies, Antineutrophil Cytoplasmic Antibody-Associated Vasculitis | Phase 1 / Phase 2 | 2024-11-04 |
| Recruiting | A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1) Lupus Nephritis, Primary Membranous Nephropathy | Phase 1 / Phase 2 | 2024-06-13 |
| Active Not Recruiting | NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell Lymphoma, Non-Hodgkin, B-cell Acute Lymphoblastic Leukemia, Large B-cell Lymphoma | Phase 1 | 2021-08-20 |
| Active Not Recruiting | NKX101, Intravenous Allogeneic CAR NK Cells, in Adults With AML or MDS Relapsed/Refractory AML, AML, Adult, MDS | Phase 1 | 2020-09-21 |